C

CNS Healthcare | Clinical Neuroscience Solutions - Memphis

Research site

(Unclaimed)

Location

6401 Poplar Avenue, Suite 420, Memphis, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Cariprazine

Atogepant

SPN-812

Testosterone

Methylphenidate

LDX

SPN-810

CNP520

Semaglutide

Loperamide

Parent organization

This site is a part of CNS Healthcare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 36 total trials

Locations recently updated

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to p...

Enrolling

Diabetes Mellitus, Type 2

Drug: Semaglutide

Drug: NNC0662-0419

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Begins enrollment this month

Obesity

Type 2 Diabetes

Drug: Cagrisema

Drug: Semaglutide

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting

Crohn's Disease

Drug: Placebo for Risankizumab IV

Drug: Risankizumab SC